
Kura Oncology (($KURA)) has held its Q3 earnings call. Read on for the main highlights of the call. Kura Oncology delivered a strongly positive earnings call, led by rapid COMZIFTI
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| KURA | Kura Oncology | 7.35 | -3.63 | -33.06% |
| Name | Price | % Change | |
|---|---|---|---|
| $7.35 | -33.06% |

Kura Oncology (($KURA)) has held its Q3 earnings call. Read on for the main highlights of the call. Kura Oncology delivered a strongly positive earnings call, led by rapid COMZIFTI

Hotter than expected CPI data on Tuesday thwarted two days worth of gains across the major average, sending Nasdaq Composite down by 0.7% and the S&P 500 by 0.4%. The

17:20 EST Kura Oncology (KURA) files automatic mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks

Kura has updated 2026 collaboration revenue guidance to $40M-$45M for 2026 and is maintaining guidance of $90M-$110M in each of 2027 and 2028. This guidance reflects non-cash accounting recognition as

Reports Q3 revenue $22.839M, consensus $23.89M. “KOMZIFTI delivered strong commercial performance this quarter, with 53% sequential revenue growth, a 30% increase in new patients starts, and continued majority share of

Kura has updated 2026 collaboration revenue guidance to $40M-$45M for 2026. This guidance reflects non-cash accounting recognition as Kura fulfills performance obligations under its agreement with Kyowa Kirin and does

Pre-earnings options volume in Kura Oncology (KURA) is 1.8x normal with puts leading calls 7:1. Implied volatility suggests the market is anticipating a move near 4.3%, or 0c, after results

Kura Oncology (KURA) is scheduled to report 3rd quarter earnings on 11/10/2026, after the market closes. Regarding Q3 estimates, Wall Street analysts expect Kura Oncology to post earnings of -$0.82

Pre-earnings options volume in Kura Oncology (KURA) is 1.4x normal with puts leading calls 10:3. Implied volatility suggests the market is anticipating a move near 7.0%, or 0c, after results

Caspian Therapeutics and Kura Oncology (KURA) announced that they plan to outline the development strategy for KO-7246, Caspian’s selective, oral menin inhibitor designed for diabetes and other chronic metabolic diseases
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| buy | Reiterated | Nov 16, 2026 | ||||
| buy | Reiterated | Nov 11, 2026 | ||||
| buy | Reiterated | Nov 11, 2026 | ||||
| buy | Reiterated | Nov 11, 2026 | ||||
| buy | Reiterated | Nov 11, 2026 | ||||
| buy | Reiterated | Nov 5, 2026 | ||||
| buy | Reiterated | Oct 29, 2026 | ||||
| buy | Reiterated | Sep 10, 2026 | ||||
| buy | Reiterated | Aug 31, 2026 | ||||
| buy | Reiterated | Aug 13, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Feb 25, 2027TBA | $688.17M | $-0.83 | $31.06M | -0.06 | -2.22 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.